Recently, much interest has focussed on the potential interaction between sympathetic nervous system and global cardiovascular risk. We investigated how baroreflex sensitivity (BRS), an index of autonomic function, interacts with central obesity (CO) in an essential hypertensive (EH) population. We selected 170 EHs and 43 normotensives (NT), (median age 47.3711.3 and 49.1713 years, respectively). Anthropometric parameters were measured for each and BRS was evaluated by a non-invasive method using Portapres TNO. The BRS evaluation was made using the sequences method. Systolic blood pressure (SBP) and heart rate were significantly higher in EH (Po0.001 and P ¼ 0.007, respectively). BRS was significantly greater in NT (P ¼ 0.02), and was associated inversely with waist circumference (WC) (P ¼ 0.005), but not with SBP or with other metabolic risk factors. Body mass index, total and high-density lipoprotein cholesterol, age and WC were not significantly different between the two groups. These results were confirmed by age pounded analysis. Finally, a separate analysis of the hypertensive group with CO (n ¼ 84) demonstrated a significantly lower BRS compared with the other hypertensive patients (n ¼ 86) (Po0.001). BRS is associated with WC but not with arterial pressure values and metabolic risk factors. Hypertensive subjects with CO show an impairment of BRS. Owing to its association with abdominal fat distribution and subsequently insulin resistance, BRS could represent a further and reliable index for evaluation of global cardiovascular risk in hypertensive patients.
Introduction
Spontaneous baroreflex sensitivity (BRS) of heart rate (HR) is a key mechanism for blood pressure homeostasis. BRS is impaired in hypertensive patients and has been demonstrated to decrease with the severity of hypertension and to be related to several cardiovascular risk factors. 1 In the ATRAMI study, La Rovere et al. 2 demonstrated that autonomic tone, assessed by HR variability and BRS, plays a pivotal role in mortality risk stratification in myocardial infarction survivors.
A central role for insulin resistance in the pathogenesis and progression of hypertension and cardiovascular risk has been reported. 3 Recent European guidelines have highlighted the role of waist circumference (WC) in the cardiovascular risk stratification of hypertensive patients, 4 considering this parameter highly associated with central body obesity, and, accordingly, with insulin resistance and dyslipidemia. In fact, arterial hypertension, insulin resistance and dyslipidemia are more typical of central rather than peripheral obesity. 5 Interestingly, available data suggest a strong association between the autonomic nervous system and insulin resistance: it has been demonstrated that increased sympathetic activation links insulin resistance with hypertension and coronary artery disease. 6 This is based on the observations that hyperinsulinemia is related to increased plasma and urinary norepinephrine levels and that subjects with insulin resistance syndrome display an increased prevalence of resistant hypertension. Furthermore, in subjects with normal or moderately elevated body weight, the level of abdominal visceral fat is related to sympathetic nerve traffic values. 7 More recently, central obesity (CO) has been characterized by a sympathetic activation greater than in peripheral obesity. 8 All of these observations underline that pathological conditions are characterized by an autonomic imbalance, with hyperactivity of sympathetic nervous system and impairment of vagal tone.
In particular, clinical features of hypertension are preceded by these balance alteration that contributes to cardiovascular risk of hypertensives patients. 9 Although the association between BRS and obesity has been well characterised, there is no available data on the association between BRS and central fat distribution in non-obese hypertensive patients.
Our issue is aimed to study the relationship between vagal tone, assessed by spontaneous BRS, and abdominal fat distribution, assessed by WC.
Materials and methods

Study population
We studied 170 non-obese outpatients with grade 1-2 essential hypertension (EH) who were seen in the Outpatient Clinic of the Hypertension Unit of the University of Torino. A group of 42 normotensive (NT) healthy volunteers were evaluated as a control group.
The study was approved by our institutional review committee and all the subjects gave their informed consent.
All the patients were asymptomatic and underwent a full medical examination to evaluate their clinical history, measurement of arterial blood pressure, HR and anthropometric parameters (height, weight, WC).
WC was measured in the standing position, using a flexible plastic tape, midway between the lower rib margin and the iliac crest.
The diagnosis of EH was reached on the basis of the standard criteria. Exclusion criteria were any associated clinical conditions (ESH-ESC 2003), 4 diabetes, obesity (body mass index (BMI)430 kg/ m 2 ), severe comorbidity and secondary hypertension, assumption of beta blockers, diltiazem, verapamil or central alpha-2 agonists.
A blood sample was taken to measure total and high-density lipoprotein (HDL) cholesterol, triglycerides and glycaemia.
In accordance to definition of metabolic syndrome by Adult Treatment Panel III (ATP III), 10 patients with three or more of following criteria were excluded: BP4130/85 mm Hg; triglycerides4 1.7 mmol/l; fasting plasma glucose46.1 mmol/l; WC4102 cm in men and 88 cm in women; HDL o1.04 mmol/l. More recently, International Diabetes Federation (IDF) defines new criteria for metabolic syndrome which include the presence of abdominal fat distribution and two or more additional factors listed in ATP III. 11 Nonetheless, the present AHA/ NHLBI statement, in contrast to IFD, maintains the ATP III criteria. This decision is based on the conclusion that ATP III criteria are simple to use in the clinical setting. 12 Therefore, we considered the direct relationship between autonomic function and body fat distribution independent of other metabolic parameters. Finally, we also divided hypertensive subjects in two subgroups: those with CO (if WC488 cm in female subjects or 4102 cm in male subjects) and those with values lower (non-central obesity -nCO).
Blood pressure measurements
All measurements were performed according to WHO-ISH recommendations. 13 Blood pressure was measured three times by the same physician using a mercury sphygmomanometer, taking the disappearance of the phase V Korotkoff sounds as diastolic pressure with the subject in a sitting position after 15 min of rest.
Patients were included in the study if their systolic blood pressure (SBP) or diastolic blood pressures (DBP) were X140 or X90, respectively, on 3 consecutive days (3 measurements per day separated by 10 min intervals) or if they were taking antihypertensive medications.
Spontaneous BRS control of HR BRS was evaluated by a continuous non-invasive method, using Portapres TNO. Patients were studied in the morning in our laboratory under controlled environmental and sound conditions. The meal before the study consisted of a light breakfast without tea or coffee, which was consumed at least 2 h before the evaluation.
At the examination, after 20 min of supine rest in a quiet room, continuous finger blood pressure was recorded by Portapres Model-2 device (TNO, Amsterdam, NL, USA) at 200 Hz sampling frequency in the supine position for 15 min.
14 BRS was calculated as described previously. 15 Briefly, BRS was assessed by the time-domain method for evaluation of spontaneous baroreflex control of HR. The time-domain method consists of computer scanning of the SBP tracing to identify sequences of X4 consecutive beats characterized by a progressive increase in SBP and a linearly related increase in pulse interval (PI) ( þ PI/ þ SBP) (correlation coefficient, rX0.85) or a progressive reduction in SBP and a linearly related decrease in PI (ÀPI/ ÀSBP) (rX0.85). The slope of the regression line between PI and SBP values within each sequence was taken as an index of BRS. All the BRS measurements were performed by the same operator (SDC). The reliability of BRS measurements was assessed by calculating intra-observer variability in 10 NT subjects. Mean average of BRS was 15.373.8 ms/mm Hg; Mean intra-observer difference was 5%; the correlation index was 78%.
Statistical analysis
Statistical analysis was conducted using SAS V8 software (SAS Institute Inc., Cary, NC, USA). The parametric distribution of the variable was analysed using a Kolmogorov-Smirnov test. Data are expressed as mean7s.d. or as median (interquartile difference) where appropriate. Differences between two groups were examined using a t-test or MannWhitney test where appropriate for normally distributed variables. A simple correlation between variable and subsequently, a linear regression analysis was used to test the association among BRS and different anthropometric variables.
Results
The anthropometric characteristics of hypertensive and NT subjects are summarized in Table 1 : the two groups were similar for sex distribution, age, BMI, WC, total and HDL cholesterol, triglycerides, and fasting glucose levels. All subjects were normoglycaemic.
As expected, SBP, DBP and HR were significantly higher in the HT group compared with NTs.
Female frequency was higher, but not statistically significant (P ¼ 0.16) in control group compared with hypertensive patients. BRS was not significantly associated to gender (P ¼ 0.5).
We have not found any significant difference about BRS between pharmacologically treated and not treated patients.
We observed an inverse association between BRS and WC (Figure 1 ), in the absence of a significant relation between BRS and the metabolic parameters (cholesterol, triglycerides, glycaemia). Furthermore, this relation was confirmed independent of blood pressure variables and after correction for age.
We also performed a stepwise linear regression analysis in order to assess the relative weight of each variable associated to BRS. WC (R 2 ¼ 0.07; P ¼ 0.005) and age (R 2 ¼ 0.11; P ¼ 0.03) accounted for 18% of the BRS variance, whereas other parameters (blood pressure, gender, cholesterol levels) did not enter into the model (Table 2) .
Finally, we divided hypertensive subjects into subgroups: those (84 subjects) with CO (if WC488 cm in female subjects or 4102 cm in male subjects) and those (86 subjects) with lower values (nCO). No patients were affected by metabolic syndrome. Hypertensives with CO displayed BRS significantly lower compared with patients with nCO ( Figure 2 ), despite the two groups displayed similar blood pressure values, HR, sex and age distribution. In NT subjects, BRS did not differ in subjects with central or non-central fat distribution. We also observed a trend towards a higher total and HDL cholesterol, triglycerides and glucose levels in hypertensive subjects with CO compared with nCO, although this did not reach statistical significance.
Discussion
In this study, we have demonstrated an association between WC and BRS: hypertensive patients with CO displayed a significant impairment in BRS compared with patients with peripheral fat distribution.
Therefore, we provide new evidence on the relationship between hypertension, the autonomic nervous system and fat distribution. We have reinforced current knowledge on the effect of central fat distribution on insulin resistance, which in turn affects BRS, by showing that even in patients without evidence of overt metabolic syndrome, Experimental studies have indicated that insulin resistance induced by a high-fat diet may occur before the onset of hypertension, 16 whereas other authors hypothesized that the association between insulin resistance and hypertension results from a primary increase in sympathetic nervous system activity. 17 Julius et al. 18 have proposed a causal role for the prevalence of sympathetic over vagal activity in determining hypertensive status and increased tendency to gain weight. Other authors have supported this hypothesis by showing that sympathetic overactivity, resulting from downregulation of the beta-adrenoreceptor-mediated thermogenic responses, could facilitate the development of obesity in hypertension. In this case, obesity would be the consequence rather than the cause of the sympathetic hyperactivity. 19 Experimental observations have shown that insulin resistance was associated with a large reduction in vagal tone, although occurs via attenuation in baroreflex activity, while this syndrome did not affect BRS via sympathetic reflex. 20 Furthermore, the development of obesity in dogs was accompanied by an attenuated resting and reflex parasympathetic control of HR. 21 Previous studies have demonstrated an altered autonomic activity in men with abdominal fat distribution compared with those with peripheral fat distribution. In obese NT subjects, 22 a significant difference in sympathetic hyperactivity, assessed by MSNA (muscle sympathetic nerve activity), has been observed between patients with or without abdominal fat distribution. Beske et al. 8 reported reduced HR responses to alterations in baroreceptor activity induced by injections of vasoactive drugs in 21 non-obese healthy men with greater compared with those with smaller quantities of visceral fat. Recently, in a selected population of the island of Linosa, it has been observed that insulin resistance is associated to an impairment of baroreflex gain, assessed by frequency domain and, in the contest of metabolic syndrome, abdominal fat distribution seems to be the strongest determinant of BRS. 23 Collectively, our observations, in accordance to previews findings, suggest that BRS might provide a synthetic early warning on autonomic disturbances in the setting of hypertension.
On the other hand, it is known that WC is an important condition in the pathogenesis of obesity and of other alterations in the metabolic profile. Recently, some authors assessed retrospectively the role of WC to predict insulin resistance, in 2746 volunteers: they observed that WC was the strongest independent risk factor for insulin resistance and BMI. Furthermore, waist to hip ratio and WC explains more than 50% of the variation in insulin sensitivity alone. 24 Furthermore, the IDF writing group considered that abdominal obesity is so highly correlated with insulin resistance that other complex measurements of insulin resistance are unnecessary. Thus, the IDF clinical definition now requests the presence of abdominal obesity for the diagnosis of metabolic syndrome.
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Abdominal fat distribution determined, at least in part, by hypersympathetic activation, is an initial condition that causes insulin resistance and, in a second time, the development of the clinical manifestations of metabolic syndrome. Considering WC as an early index of metabolic alteration, it would be therefore interesting to investigate if a reduction on BRS could be an early sign of autonomic imbalance in hypertensive patients with CO, by assessing their risk to develop metabolic syndrome. Furthermore, it would be worth testing, if a significant weight loss can improve baroreflex responsiveness; in fact several studies have demonstrated that abdominal fat loss results in an improvement of the metabolic response to exercise training and in a reduction of metabolic complications. 25 Weight loss determined by a hypocaloric diet diminishes sympathetic nervous system activation in subjects with metabolic syndrome, probably through a reduction in leptin concentration and an improvement in insulin sensitivity resulting in an improvement in cardiac baroreflex function. 26 It is well known that BRS tends to decline with aging, 27 despite this, we would like to emphasize that in our study BRS was not influenced by age. Our results could be explained by previous studies demonstrating that abdominal to peripheral fat distribution explains a significant portion of the variance in autonomic functions attributed to age. 28 The absence of linear correlation between fat distribution and age in our study is probably because our population was relatively young.
One limit of our study is that we tested sympathetic activity indirectly, using time-domain analysis in assessment of BRS of HR. HR baroreflex in hypertensive patients is only a surrogate of hypersympathetic tone, that is probably increased in a number of vascular districts. 29 Furthermore, hypertensive subjects are often characterized by a reduced vagal tone, 30 which acts in addition to the chronotropic influence of the increased sympathetic drive.
In conclusion, this is the first study that demonstrates a direct link between spontaneous BRS and fat distribution in a hypertensive population, showing an impairment of BRS in EHs with CO.
In accordance with several previous studies, the autonomic nervous system impairment plays a pivotal role in hypertensive patients with insulin resistance, increasing abdominal fat distribution and secondary metabolic alterations.
The clinical implication of our study is that the greater risk of cardiovascular complications seen in subjects with CO may depend not only on metabolic factors but also on the enhanced sympathetic cardiovascular drive, given the deleterious effects of this alteration on cardiac, vascular and metabolic variables. Further studies are needed to test a possible causal role of autonomic imbalance in the development of metabolic syndrome in subjects with abdominal fat distribution.
